Drreddys Laboratories | Betriebsaufwand



Operating Expenses Veränderung Datum
ANI Pharmaceuticals USD 194.95M 211M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Canopy Growth CAD 98.58M 10.03M 2024-12
Cipla INR 53.64B 164.8M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Drreddys Laboratories INR 64.87B 2.26B 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Lonza CHF 2.52B 776M 2024-06
Novartis USD 11.28B 1.73B 2024-12
Pacira USD 162.55M 145.55M 2024-12
Prestige Brands USD 198.36M 1.09M 2024-12
Richter Gedeon HUF 153.02B 2.72B 2024-09
Sun Pharmaceuticals INR 104.3B 3.51B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12



Drreddys Laboratories Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.